We are monitoring the impact of COVID-19 on APAC Contrast Media Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3286
Share on
Share on

Asia-Pacific Contrast Media Market Research Report - Segmented By Medical Procedure, Route of Administration, Type, Indication, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3286
Pages: 145

APAC Contrast Media Market Size (2021 to 2026)

The size of the Asia Pacific contrast media market has been forecasted at USD 1.02 Billion in 2021. Furthermore, it is estimated to grow at a CAGR of 3.9% and be worth USD 1.23 billion by 2026. Thus, the Asia Pacific contrast media market is rising at a promising speed.

The rising frequency of chronic diseases, the increasing number of contrast agent approvals, the growing number of examinations conducted, the expanding number of diagnostic centers and hospitals, and the availability of reimbursement are primarily accelerating the market's growth in Asia. As a result, players in the market should expect excellent growth opportunities in emerging markets in Asian countries. In addition, diagnostic imaging tests have increased as the prevalence of long-term diseases, and complex comorbidities have increased. Ultrasound, X-rays and advanced imaging technologies like Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans are all instances of this.

The use of image-guided treatments can aid in determining whether malignancy is malignant or benign. With time, image-guided surgeries (IGS) are increasing in popularity. These methods can be used to diagnose and treat a variety of illnesses. The growing necessity for and desire for imaging refinement during surgeries necessitates novel data collecting methods. This need is best met by image-guided procedures, which has resulted in increased demand for diagnosis and treatment and has contributed to market expansion. With numerous forms of chronic diseases on the rise, demand for diagnostic imaging is at an all-time high.

Due to the patent expiration of branded contrast media products, competition in the contrast media market is projected to heat up significantly in the next few years. This will allow generic counterparts, which are less expensive than commercially available branded agents, to enter the market. Among all the services given by physicians, the number of imaging services per Medicare beneficiary has increased the most. Its dominance is partly due to favorable regulations, a well-developed healthcare infrastructure, and the rapid adoption of new medical technologies.

Advanced treatments' high cost and inaccessibility are expected to limit the market's growth rate to some extent. In addition, specific adverse effects and allergic responses linked to its use may stifle market expansion for some time. Their side effects range from mild to severe; severe reactions are infrequent, as are significant allergic reactions to contrast materials. A scarcity of specialists and radiologists would hamper the market expansion.

This research report on the Asia-Pacific contrast media market has been segmented and sub-segmented into the following categories:

By Medical Procedure:         

  • X-Ray/CT  
  • MRI            
  • Ultrasound              

By Route of Administration:

  • Injectable Contrasts Media             
  • Oral Contrasts Media         
  • Rectal Contrasts Media     
  • Urethral Contrasts Media

By Type:

  • Iodinated
  • Gadolinium-Based
  • Microbubble
  • Barium- Based

By Indications: 

  • Cardiovascular Disorders
  • Oncology
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Musculoskeletal Disorders    

By Application: 

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

In 2020, Asia Pacific retained a sizable market share. This is due to the presence of well-established local and international manufacturers in the area. For example, General Electric Pharmaceuticals (Shanghai) Co., Ltd. is a GE Healthcare subsidiary that manufactures diagnostic pharmaceuticals (CT/MR contrast media) in China. It is one of the world's most extensive contrast media manufacturing facilities. In this collection of regional markets, China will continue to be one of the fastest expanding. The Asia-Pacific market is led by countries like Australia, India, and South Korea. Increased research and development activities in imaging modalities demand image-guided procedures, which contribute to an aging population. Therefore, China and India are projected to see a surge in demand due to their large population.

KEY MARKET PLAYERS:

A few of the notable companies operating in the APAC contrast media market profiled in the report are CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), and Subhra Pharma Private Limited (India).

1.Introduction          

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions 

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary 

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints     

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                              

                5.1 Medical Procedure   

                                5.1.1 Introduction                                           

                                5.1.2 X-Ray/CT                                  

                                5.1.3 MRI                                            

                                5.1.4 Ultrasound                                              

                                5.1.5  Y-o-Y Growth Analysis, By Medical Procedure                                        

                                5.1.6  Market Attractiveness Analysis, By Medical Procedure                                      

                                5.1.7  Market Share Analysis, By Medical Procedure                                        

                5.2 Route of Administration        

                                5.2.1 Introduction                                           

                                5.2.2 Injectable Contrasts Media                                              

                                5.2.3 Oral Contrasts Media                                          

                                5.2.4 Rectal Contrasts Media                                      

                                5.2.5 Urethral Contrasts Media                                 

                                5.2.6 Y-o-Y Growth Analysis, By Route of Administration                                               

                                5.2.7 Market Attractiveness Analysis, By Route of Administration                                             

                                5.2.8 Market Share Analysis, By Route of Administration                                              

                5.3 Type      

                                5.3.1 Introduction                                           

                                5.3.2 Iodinated Contrasts Media                                              

                                5.3.3 Gadolinium-Based Contrasts Media                                             

                                5.3.4 Microbubble Contrasts Media                                        

                                5.3.5 Barium- Based Contrasts Media                                     

                                5.3.6 Y-o-Y Growth Analysis, By Type                                     

                                5.3.7  Market Attractiveness Analysis, By Type                                  

                                5.3.8  Market Share Analysis, By Type                                    

                5.4  Indications  

                                5.4.1 Introduction                                           

                                5.4.2 Cardiovascular Disorders                                   

                                5.4.3 Oncology                                 

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Gastrointestinal Disorders                                

                                5.4.6 Nephrological Disorders                                    

                                5.4.7 Musculoskeletal Disorders

                                5.4.8 Y-o-Y Growth Analysis, By  Indications                                        

                                5.4.9  Market Attractiveness Analysis, By  Indications                                     

                                5.4.10  Market Share Analysis, By  Indications                                     

                5.5 Application  

                                5.5.1 Introduction                                           

                                5.5.2 Radiology                                 

                                5.5.3 Interventional Cardiology                                 

                                5.5.4 Interventional Radiology                                   

                                5.5.5 Y-o-Y Growth Analysis, By  Application                                        

                                5.5.6  Market Attractiveness Analysis, By Application                                      

                                5.5.7  Market Share Analysis, By Application                                       

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Medical Procedure                    

6.1.3.3 By Route of Administration                          

6.1.3.4 By Type                 

6.1.3.5 By Indication                       

6.1.3.6 By Application                    

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Medical Procedure                    

6.1.4.3 By Route of Administration                          

6.1.4.4 By Type                 

6.1.4.5 By Indication                       

6.1.4.6 By Application                    

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Medical Procedure                    

6.1.5.3 By Route of Administration                          

6.1.5.4 By Type                 

6.1.5.5 By Indication                       

6.1.5.6 By Application                    

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia       

7.Strategic Analysis                

                7.1 PESTLE analysis 

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                 

                8.1 GE Healthcare   

                                8.1.1 Overview                                 

                                8.1.2 Medical Procedure Analysis                                             

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Spago Nanomedical AB 

                8.3 Subhra Pharma Private Limited  

                8.4 Daiichi Sankyo   

                8.5 CMC Contrast AB      

                8.6 Nanopet Pharma GmbH        

                8.7 Guerbet Group

                8.8 Bracco Imaging S.P.A      

                8.9 Bayer AG      

                8.10 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)    

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables 

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Contrast Media Market, By Procedure, From 2021 to 2026 (USD Million)
  2. Asia Pacific X-ray/Computed Tomography (CT) Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Magnetic Resonance Imaging (MRI) Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Ultrasound Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Contrast Media Market, By Route of Administration, From 2021 to 2026 (USD Million)
  6. Asia Pacific Oral Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Injectable Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific Rectal Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Urethral Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Contrast Media Market, By Type, From 2021 to 2026 (USD Million)
  11. Asia Pacific Barium-Based Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Iodinated Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia Pacific Gadolinium-Based Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Microbubble Contrast Media Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia Pacific Contrast Media Market, By Indication, From 2021 to 2026 (USD Million)
  16. Asia Pacific Cardiovascular Disorders Market, By Region, From 2021 to 2026 (USD Million)
  17. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia Pacific Gastrointestinal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  19. Asia Pacific Musculoskeletal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  20. Asia Pacific Neurological Disorders Market, By Region, From 2021 to 2026 (USD Million)
  21. Asia Pacific Nephrological Disorders Market, By Region, From 2021 to 2026 (USD Million)
  22. Asia Pacific Contrast Media Market, By Application, From 2021 to 2026 (USD Million)
  23. Asia Pacific Radiology Market, By Region, From 2021 to 2026 (USD Million)
  24. Asia Pacific Interventional Radiology Market, By Region, From 2021 to 2026 (USD Million)
  25. Asia Pacific Interventional Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  26. Japan Contrast Media Market, By Procedure, From 2021 to 2026 (USD Million)
  27. Japan Contrast Media Market, By Route of Administration, From 2021 to 2026 (USD Million)
  28. Japan Contrast Media Market, By Type, From 2021 to 2026 (USD Million)
  29. Japan Contrast Media Market, By Indication, From 2021 to 2026 (USD Million)
  30. Japan Contrast Media Market, By Application, From 2021 to 2026 (USD Million)
  31. China Contrast Media Market, By Procedure, From 2021 to 2026 (USD Million)
  32. China Contrast Media Market, By Route of Administration, From 2021 to 2026 (USD Million)
  33. China Contrast Media Market, By Type, From 2021 to 2026 (USD Million)
  34. China Contrast Media Market, By Indication, From 2021 to 2026 (USD Million)
  35. China Contrast Media Market, By Application, From 2021 to 2026 (USD Million)
  36. India Contrast Media Market, By Procedure, From 2021 to 2026 (USD Million)
  37. India Contrast Media Market, By Route of Administration, From 2021 to 2026 (USD Million)
  38. India Contrast Media Market, By Type, From 2021 to 2026 (USD Million)
  39. India Contrast Media Market, By Indication, From 2021 to 2026 (USD Million)
  40. India Contrast Media Market, By Application, From 2021 to 2026 (USD Million)
  41. Australia Contrast Media Market, By Procedure, From 2021 to 2026 (USD Million)
  42. Australia Contrast Media Market, By Route of Administration, From 2021 to 2026 (USD Million)
  43. Australia Contrast Media Market, By Type, From 2021 to 2026 (USD Million)
  44. Australia Contrast Media Market, By Indication, From 2021 to 2026 (USD Million)
  45. Australia Contrast Media Market, By Application, From 2021 to 2026 (USD Million)
  46. South Korea Contrast Media Market, By Procedure, From 2021 to 2026 (USD Million)
  47. South Korea Contrast Media Market, By Route of Administration, From 2021 to 2026 (USD Million)
  48. South Korea Contrast Media Market, By Type, From 2021 to 2026 (USD Million)
  49. South Korea Contrast Media Market, By Indication, From 2021 to 2026 (USD Million)
  50. South Korea Contrast Media Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample